HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

C817 curcumin derivative

antineoplastic; structure in first source

Also Known As:

curcumin derivative C817

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Diarylheptanoids: 471
        Curcumin: 10678
        C817 curcumin derivative: 1
      - Benzene Derivatives: 17
        Phenols: 677
        Catechols: 121
        Curcumin: 10678
        C817 curcumin derivative: 1
  - Acyclic Hydrocarbons
    - Alkanes: 241
      - Heptanes: 70
        Diarylheptanoids: 471
        Curcumin: 10678
        C817 curcumin derivative: 1

Experts

1.	Chen, Rui-jia: 1 article (03/2014)
2.	Chen, Yuan-zhong: 1 article (03/2014)
3.	Huang, Li-sen: 1 article (03/2014)
4.	Liu, Yang: 1 article (03/2014)
5.	Lou, Li-guang: 1 article (03/2014)
6.	Wu, Li-xian: 1 article (03/2014)
7.	Wu, Ying: 1 article (03/2014)
8.	Xu, Jian-hua: 1 article (03/2014)
9.	Zheng, Zhi-hong: 1 article (03/2014)

Related Diseases

1.	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/01/2014 - "Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro."

Related Drugs and Biologics

1.	Imatinib Mesylate (Gleevec)